301 related articles for article (PubMed ID: 17912085)
1. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.
Agrillo A; Ungari C; Filiaci F; Priore P; Iannetti G
J Craniofac Surg; 2007 Sep; 18(5):1071-5. PubMed ID: 17912085
[TBL] [Abstract][Full Text] [Related]
2. Ozone therapy in extractive surgery on patients treated with bisphosphonates.
Agrillo A; Sassano P; Rinna C; Priore P; Iannetti G
J Craniofac Surg; 2007 Sep; 18(5):1068-70. PubMed ID: 17912084
[TBL] [Abstract][Full Text] [Related]
3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
Tirelli G; Biasotto M; Chiandussi S; Dore F; De Nardi E; Di Lenarda R
Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
[TBL] [Abstract][Full Text] [Related]
5. New therapeutic protocol in the treatment of avascular necrosis of the jaws.
Agrillo A; Petrucci MT; Tedaldi M; Mustazza MC; Marino SM; Gallucci C; Iannetti G
J Craniofac Surg; 2006 Nov; 17(6):1080-3. PubMed ID: 17119409
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
Favia G; Pilolli GP; Maiorano E
J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
[TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.
Freiberger JJ; Padilla-Burgos R; Chhoeu AH; Kraft KH; Boneta O; Moon RE; Piantadosi CA
J Oral Maxillofac Surg; 2007 Jul; 65(7):1321-7. PubMed ID: 17577496
[TBL] [Abstract][Full Text] [Related]
8. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
[TBL] [Abstract][Full Text] [Related]
9. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of bisphosphonate induced osteonecrosis of the jaws.
Williamson RA
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):251-5. PubMed ID: 20015614
[TBL] [Abstract][Full Text] [Related]
14. [Management of complications of bisphosphonates in oncology patients: jaw osteonecrosis].
Madrid C; Jaques B; Bouferrache K; Broome M
Rev Med Suisse; 2007 May; 3(112):1322, 1324-6, 1329-31. PubMed ID: 17596069
[TBL] [Abstract][Full Text] [Related]
15. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S
Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160
[TBL] [Abstract][Full Text] [Related]
16. Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
Kyrgidis A; Koloutsos G; Vahtsevanos K
Head Neck; 2009 Aug; 31(8):1112-3; author reply 1113-4. PubMed ID: 19572289
[No Abstract] [Full Text] [Related]
17. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
18. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
Clarke BM; Boyette J; Vural E; Suen JY; Anaissie EJ; Stack BC
Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment.
Pérez SB; Barrero MV; Hernández MS; Knezevic M; Navarro JM; Millares JR
Med Oral Patol Oral Cir Bucal; 2008 Dec; 13(12):E770-3. PubMed ID: 19047964
[TBL] [Abstract][Full Text] [Related]
20. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
